Implantable Cardiac Pacemaker Market - Global Forecast, 2022 - 2028

Implantable Cardiac Pacemaker Market - Global Forecast, 2022 - 2028

Report Description
Implantable cardiac pacemaker is a small device implanted in the chest or abdomen for the treatment of abnormal heart rhythms, arrhythmia, heart block, and atrial fibrillation. Implantable cardiac pacemaker is evolved from battery-powered transistorized wearable pacemakers to current leadless pacemaker, an entire pacemaker which is placed within cardiac chambers. Cardiac pacemakers are used to treat abnormal electrical signaling in the heart, which causes arrhythmias. Implantable cardiac pacemaker use low-energy electrical signals to speed up the slow heartbeat, help to control an abnormal and fast heart rhythm, and prevents long QT syndrome, a disorder of the heart’s electrical activity, which causes sudden, uncontrollable, and dangerous arrhythmias.
Market Dynamics
Market players are engaged in developing novel pacemakers with ability to control the abnormal heart rhythm, monitor and record patient’s heart's electrical activity, blood temperature, and breathing rate. Technological advances in the field of implantable cardiac pacemakers along with increasing prevalence of cardiovascular disease is projected to drive the growth of implantable cardiac pacemaker market over the forecast period.
Key features of the study:
This report provides in-depth analysis of implantable cardiac pacemaker in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global implantable cardiac pacemaker market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Medtronic plc, BIOTRONIK, Inc., Boston Scientific Corporation, St. Jude Medical, Vitatron Holding B.V., Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PLC and Qinming Medical.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
The global implantable cardiac pacemaker market report caters to various stakeholders in this industry including investors, suppliers, implantable cardiac pacemakers manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the implantable cardiac pacemaker market.
Detailed Segmentation:
Global Implantable Cardiac Pacemaker Market, By Product Type:
Single Chamber Pacemaker
Dual Chamber Pacemaker
Biventricular Pacemaker
Global Implantable Cardiac Pacemaker Market, By Application:
Heart Block
Arrhythmia
Atrial fibrillation
Long QT Syndrome
Bradycardia
Tachycardia
Others
Global Implantable Cardiac Pacemaker Market, By End User:
Hospitals
Emergency Care Centers
Others
Global Implantable Cardiac Pacemaker Market, By Region:
North America
By Country:
U.S.
Canada
By Product Type:
Single Chamber Pacemaker
Dual Chamber Pacemaker
Biventricular Pacemaker
By Application
Heart Block
Arrhythmia
Atrial fibrillation
Long QT Syndrome
Bradycardia
Tachycardia
Others
By End User:
Hospitals
Emergency Care Centers
Others
Europe
By Country:
Germany
France
Italy
UK
Spain
Russia
Rest of Europe
By Product Type:
Single Chamber Pacemaker
Dual Chamber Pacemaker
Biventricular Pacemaker
By Application
Heart Block
Arrhythmia
Atrial fibrillation
Long QT Syndrome
Bradycardia
Tachycardia
Others
By End User:
Hospitals
Emergency Care Centers
Others
Asia Pacific
By Country:
China
India
Japan
South Korea
Australia
Rest of Asia Pacific
By Product Type:
Single Chamber Pacemaker
Dual Chamber Pacemaker
Biventricular Pacemaker
By Application
Heart Block
Arrhythmia
Atrial fibrillation
Long QT Syndrome
Bradycardia
Tachycardia
Others
By End User:
Hospitals
Emergency Care Centers
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product Type:
Single Chamber Pacemaker
Dual Chamber Pacemaker
Biventricular Pacemaker
By Application
Heart Block
Arrhythmia
Atrial fibrillation
Long QT Syndrome
Bradycardia
Tachycardia
Others
By End User:
Hospitals
Emergency Care Centers
Others
Latin America
By Country:
Brazil
Argentina
Mexico
Rest of Latin America
By Product Type:
Single Chamber Pacemaker
Dual Chamber Pacemaker
Biventricular Pacemaker
By Application
Heart Block
Arrhythmia
Atrial fibrillation
Long QT Syndrome
Bradycardia
Tachycardia
Others
By End User:
Hospitals
Emergency Care Centers
Others
Africa
By Country:
South Africa
Central Africa
North Africa
By Product Type:
Single Chamber Pacemaker
Dual Chamber Pacemaker
Biventricular Pacemaker
By Application
Heart Block
Arrhythmia
Atrial fibrillation
Long QT Syndrome
Bradycardia
Tachycardia
Others
By End User:
Hospitals
Emergency Care Centers
Others
Company Profiles
Medtronic plc *
Company Overview
Product Portfolio
Financial Performance
Recent Developments
Strategies
BIOTRONIK, Inc.
Boston Scientific Corporation
St. Jude Medical
Vitatron Holding B.V.
Shree Pacetronix Ltd.
MEDICO S.p.A.
Lepu Medical Technology Co Ltd.
LivaNova PLC
Qinming Medical
“*” marked represents similar segmentation in other categories in the respective section.